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UNIVERSITY OF MASSACHUSETTS CENTER FOR CLINICAL & TRANSLATIONAL SCIENCE  
5TH ANNUAL RESEARCH RETREAT 
May 20, 2014 
Albert Sherman Center, UMMS Worcester campus 
 
MINI SYMPOSIA PROGRAM 
11:00 AM – 12:30 PM 1. Polyphenols: Eat, Drink and Be Healthy 
Moderators: Mahdi Garelnabi, Catherine Neto, and Thomas A. Wilson 
Room:  Multi-Purpose Room EAST, Albert Sherman Center 
2. Creating Devices for Personalized Health Monitoring 
Moderator: Joseph Jerry 
Room:  Multi-Purpose Room WEST, Albert Sherman Center 
3. Finding Signals Amidst the Noise 
Moderator: Anthony Carruthers 
Room:  Auditorium, Albert Sherman Center 
4. Can Simply Paying Attention Change Behavior? Emotion and Behavior Regulation Through 
Meditation 
Moderator: Judy Ockene 
Room:  Hiatt Auditorium, UMass Medical School (1st floor) 
2:30 PM – 4:00 PM 5. Utilizing Community Voices to Translate Research into Communities: Results from Three 
Pilot Studies Conducted by Academic and Community Partnerships 
Moderator: Ira Ockene 
Room:  Multi-Purpose Room EAST, Albert Sherman Center 
6. Data Acquisition, Data Management, and Subject Tracking in Clinical and Translational 
Research: Seeking Solutions to Persistent Challenges 
Moderators: Mary Costanza and Bruce Barton 
Room:  Auditorium, Albert Sherman Center 
7. Divergent Impacts of Physical Activity and Sedentary Behavior on Glucose Intolerance and 
Vascular Function: From Laboratory to Clinic 
Moderators: Barry Braun and Sheila Chauhan 
Room:  Hiatt Auditorium, UMass Medical School (1st floor) 
8. Physical Activity, Sedentary Behavior and Function in Individuals with Knee and Hip 
Osteoarthritis: Clinical Observations and Opportunities for Future 
Moderator: David Ayers 
Room:  Multi-Purpose Room WEST, Albert Sherman Center 
4:00 PM – 5:30 PM 9. Manipulating the Gut Microbiome for Human Health 
Moderators: Beth McCormick and Jeffrey Blanchard 
Room:  Auditorium, Albert Sherman Center 
10. Systems Science and Health: Using Analytical Approaches to Evaluate Healthcare Policy 
Decisions 
Moderators: Isa Bar-On and Allison Rosen 
Room:  Multi-Purpose Room EAST, Albert Sherman Center 
11. Advanced Computational and Technological Approaches to Mitigating Mobility Dysfunction 
in People with Multiple Sclerosis 
Moderator: Richard van Emmerik 
Room:  Multi-Purpose Room WEST, Albert Sherman Center 
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1. Polyphenols: Eat, Drink and Be Healthy 
 
Moderators: Mahdi Garelnabi, MSc. MLT, PhD, Assistant Professor, Department of Clinical Laboratory and 
Nutritional Sciences, University of Massachusetts Lowell 
 
Catherine C. Neto, PhD, Professor, Department of Chemistry and Biochemistry, University of 
Massachusetts Dartmouth 
 
Thomas A. Wilson, PhD, MPH, LDN, Associate Professor, Department of Clinical Laboratory 
and Nutritional Sciences, University of Massachusetts Lowell 
 
Presenters: Barabara Shukitt-Hale, PhD, Research Physiologist, Neuroscience and Aging Laboratory, 
Tufts USDA-ARS-HNRCA 
 
Julia J. Peterson, PhD, Adjunct Assistant Professor, Friedman School of Nutrition Science and 
Policy, Tufts University School of Medicine 
 
Background and Purpose: 
Polyphenols include a diverse group of naturally-occurring flavonoids, tannins, and stilbenes. These molecules 
are found in many vegetables and fruits such as onions, cranberry and grape; as well as their processed 
byproducts such as red wine and chocolates, spices, "nutraceutical" supplements, herbals and botanical 
preparations. Several polyphenols are known to have beneficial health effects because of their antioxidant 
properties and their anti-inflammatory inhibitory role.  Recent data from human studies and animal models 
experiments have shown that phytochemical compounds have anti-cancer, and cardiovascular and 
neurological protective roles. The goal of this mini symposium is to highlight the beneficial health effect of 
flavonoids by presenting the current scientific understanding from the basic laboratory research and evidences 
from clinical studies. The four presenters are expected to share data from their research in areas covering 
areas such as infection, cancer, cardiovascular and neurological diseases. 
 
This mini-symposium will provide an interdisciplinary and translational aspect of polyphenol antioxidants and is 
expected to be attended by a wide audience of researchers interested in diseases mentioned above and on 
the role of antioxidants in health and disease.  
 
Format: 
We propose an invited key speaker from the Antioxidants Research Laboratory at Tufts University speaking for 
30 minutes including discussion and 3 additional presentations 15 minutes each followed by 5 minutes 
discussion for a total of 20 minutes slot. 
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2. CREATING DEVICES FOR PERSONALIZED HEALTH MONITORING 
 
Moderator: Joseph Jerry, PhD, Professor Department of Veterinary and Animal Science, University of 
Massachusetts Amherst; Science Director, Pioneer Valley Life Sciences Institute; Co-Director, 
Rays of Hope Center for Breast Cancer Research 
 
Presenters: David D. McManus, MD, ScM, FACC, FHRS, Assistant Professor of Medicine, Section of 
Cardiac Electrophysiology, University of Massachusetts Medical School and Worcester 
Polytechnic Institute 
 
Patty Freedson, PhD, Professor and Chair, Department of Kinesiology, University of 
Massachusetts Amherst 
 
Christopher Salthouse, PhD, Dev and Linda Gupta Assistant Professor, Department of 
Electrical and Computer Engineering, University of Massachusetts Amherst 
 
Jeffrey Morse, PhD, Managing Director, National Nanomanufacturing Network, Center for 
Hierarchical Manufacturing, University of Massachusetts Amherst 
 
Background, Purpose, and Scientific Issues to be addressed: 
Background: This past summer Governor Patrick announced a $100 million grant from the Massachusetts Life 
Science Center for life sciences capital projects and includes $95 million for UMass Amherst.  The grant will 
foster increased engagement with industry partners and institutions such as the University of MA Medical 
School.  Three centers were funded including the Center for Personalized Health Monitoring (CPHM).  The 
CPHM is an interdisciplinary research, training, and technology development center in wearable sensor 
systems for personalized health and biometric monitoring.  CPHM’s mission is to conduct basic and 
translational research with world-leading impact across the entire technical roadmap for advanced 
personalized health monitoring for acute care and tele-medicine settings. 
 
Purpose: This mini-symposium will present examples of applications of personalized health monitors and 
technical capabilities available through CPHM.  Dr. McManus will present recent work related to cardiac 
monitoring using smartphone and bioimpedance sensors, including arrhythmia, blood volume, and heart failure 
monitoring.  Dr. Freedson will highlight her group’s research on the calibration and validation of wearable 
physical activity sensors and how these sensors are used to examine the relationship between physical activity 
dose and health-related responses.  She will also discuss research pertaining to sleep monitoring sensors 
conducted by Dr. Rebecca Spencer in the Department of Psychology.  Dr. Salthouse will discuss the expertise 
and tools available in CPHM to develop instruments to digitize biology giving examples from his current 
projects to build a point-of-care flow cytometer and a non-intrusive head and eye tracking system.  Dr. Morse 
will discuss advances in transitioning nanofabrication processes for realizing sensors for personalized health 
monitoring, including the development of wearable microfluidic sensors for detection of biomarkers indicative of 
stress and fatigue.  Examples from current projects include nanoparticle field effect transistor (FET) sensors, 
printed microfluidics, and replication of antimicrobial/anti-fouling surfaces via high throughput, roll-to-roll 
processes.  
 
Scientific Opportunities: We will provide a framework for how the CPHM research laboratories, industry 
partners, and UMass Medical School collaborators can be integrated to produce novel wearable sensors to 
assess behaviors and biomarkers related to human health.  Giles Whalen, MD, Department of Surgery or 
James Liebmann, MD, Department of Medicine, University of MA Medical School, will participate in the Panel 
Discussion providing insights into needs and applications of monitors in oncology. 
 
Format:  
Introduction (5 min): Joseph Jerry  
Four speakers (60 min total): 15 minute presentations by Drs. McManus, Freedson, Salthouse, and Morse 
Panel Discussion (25 min): Pose issues for discussion and feedback of collaborations between CPHM and 
clinical partners at UMMS  
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3. FINDING SIGNALS AMIDST THE NOISE 
 
Moderator: Anthony Carruthers, PhD, Professor and Dean, Graduate School of Biomedical Science, 
University of Massachusetts Medical School 
 
Presenters: Wes Salomon, PhD Candidate, Zamore Laboratory, University of Massachusetts Medical 
School 
 
Victor Serebrov, PhD, Research Instructor, Moore Laboratory, University of Massachusetts 
Medical School 
 
Kate Lapane, PhD, Associate Dean, Graduate School of Biomedical Science; Director, 
Doctoral Program in Clinical & Population Health Research; Professor, Division of Epidemiology 
of Chronic Diseases and Vulnerable Populations, University of Massachusetts Medical School 
 
David Grunwald, PhD, Assistant Professor, Biochemistry and Molecular Pharmacology, 
University of Massachusetts Medical School 
 
Arlene Ash, PhD, Professor and Division Chief, Division of Biostatistics and Health Sciences 
Research, Department of Quantitative Health Sciences, University of Massachusetts Medical 
School 
 
Manuel Garber, PhD, Associate Professor and Director, Bioinformatics Core Facility, 
Department of Quantitative Health Sciences, University of Massachusetts Medical School 
 
 
Presentations: 
RISCy business        Salomon and Serebrov 
 
The promise and perils of pharmacoepidemiology    Lapane 
 
In motley pictures with a little clarity, much error and a spark of verity Grunwald 
 
Predicting key healthcare outcomes      Ash 
 
The ups and downs of genomic analysis     Garber 
 
Moderated Panel Discussion       All presenters 
 
Format: 
Five, short presentations (10 minutes) followed by a moderated panel discussion. 
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4. CAN SIMPLY PAYING ATTENTION CHANGE BEHAVIOR? EMOTION AND BEHAVIOR REGULATION 
THROUGH MEDITATION 
 
Moderator: Judy Ockene, PhD, MEd, MA, Professor, Department of Medicine, University of 
Massachusetts Medical School 
 
Presenters: Wenjun Li, PhD, Associate Professor, Department of Medicine, University of Massachusetts 
Medical School 
 
Carl Fulwiler, MD, PhD, Associate Professor, Department of Psychiatry, University of 
Massachusetts Medical School 
 
Judson Brewer, MD, PhD, Associate Professor, Departments of Medicine and Psychiatry, 
University of Massachusetts Medical School 
 
Background and Purpose: 
Why do we eat cookies when we are anxious?  Why do we smoke when we are stressed?  And what can we 
do about this?  Much progress has been made over the past several decades in elucidating the psychological 
and neurobiological mechanisms underlying emotional and cognitive regulation.  Cognitive Behavioral Therapy 
has shown that we can retrain our minds to reduce depressive symptoms and stop using drugs.  And more 
recently, this type of cognitive control has been shown to involve the prefrontal cortex exerting “top-down” 
control of evolutionarily older brain structures such as the limbic system. 
 
However, the prefrontal cortex is also the first structure to become less functional during anxious or stressful 
situation; and it has also been suggested that will power can be depleted, which may suggest at least in part 
why cognitive therapy success rates are far below 50%.  Recently, mindfulness training, which helps 
individuals pay attention to their present moment experience, and in doing so, “let go” when they are 
perpetuating unhealthy habit patterns, has been shown to effectively treat depression, anxiety and intractable 
pain, and even double the quit rates for smokers compared to “gold-standard” cognitive therapy.  From a 
neurobiological perspective, mindfulness seems to enlist brain structures involved in self-referential 
processing, suggesting an entirely different, potentially powerful and lasting mechanism of behavioral change. 
 
In this mini symposium, we will briefly present clinical and translational data showing how mindfulness training 
affects clinically relevant problems such as emotional eating and smoking, and how it changes network 
connectivity and activation of relevant brain structures.  Specifically, Dr. Fulwiler will present preliminary data 
on changes in emotional eating following mindfulness training and neuroimaging studies on changes in 
emotion regulation pathways that may explain how mindfulness may be helpful for maintaining healthy 
behaviors.  Next, Dr. Brewer will briefly present studies that used conventional and real-time fMRI to 
investigate the neurobiological mechanisms of mindfulness comparing novice and experienced meditators.  He 
will also present ongoing work aimed to test the utility of neuro-feedback as an augmentation strategy for 
mindfulness training.  Finally, Dr. Li will present the overarching design and progress on the development of 
International Network of Data Registries for Advancing Mindfulness Practice, Education and Research 
(INDRA-M).  INDRA-M is designed for the mindfulness profession, and to support comparative effectiveness 
research through systematic prospective data collection across multiple practices in 56 countries.  It will 
support research on weight loss/obesity prevention, smoking cessation, pain management, stress reduction 
and work productivity, and long-term return-on-investment analysis. 
 
Format: 
Each presentation will be a maximum of 15 minutes, which expressly is intended to foster discussion around 
the issues related the similarities and differences between cognitive and mindfulness techniques, as well as 
the promises and challenges in translating mechanistic findings into clinical practice.  The discussion will be led 
off by Dr. Ockene, who will give a brief description of key elements of the mechanisms underlying cognitive 
therapies. 
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5. UTILIZING COMMUNITY VOICES TO TRANSLATE RESEARCH INTO COMMUNITIES: RESULTS 
FROM THREE PILOT STUDIES CONDUCTED BY ACADEMIC AND COMMUNITY PARTNERSHIPS 
 
Moderator: Ira S. Ockene, MD, David and Barbara Milliken Professor of Preventive Cardiology; 
Cardiovascular Medicine; Director of the UMass CCTS Community Engagement and Research 
Section, University of Massachusetts Medical School 
 
Presenters: A) Elmer R. Freeman, MSW, Center for Community Health Education Research and Service 
 
B) Heather-Lyn Haley, PhD, Assistant Professor, Family Medicine and Community Health, 
University of Massachusetts Medical School and Valerie Zolezzi-Wyndham, Esq., Community 
Legal Aid 
 
C) Jeroan Allison, MD, MS, Professor, Department of Quantitative Health Sciences, University 
of Massachusetts Medical School and Marie Boone, MHS, Vice President, Mosaic Cultural 
Complex (Mosaic) 
 
Background and Purpose: 
The mission of the Community Engagement and Research Section of the UMass Center for Clinical and 
Translational Science is to improve health in Massachusetts by fostering community engaged research among 
UMass researchers and community partners.  One mechanism to foster this research approach is through pilot 
funding for community translational research.  Our pilot awards focus on community engaged research defined 
as “the process of working collaboratively with and through groups of people affiliated by geographic proximity, 
special interest, or similar situations to address issues affecting well-being of those people” (CDC, 1997).  Our 
three 2013 awardees will present their collaborative research projects, outcomes and future plans.  The 
session will provide an opportunity for the cross-fertilization of ideas and experiences, and will bring together 
people with diverse interests from different community organizations.  The three presentations will be: 
A) Resilient, Active and Vibrant Elders (RAVE); Elmer R. Freeman, MSW, Center for Community 
Health Education Research and Service.  RAVE is an exploratory study of barriers to chronic disease 
management among Black and Latino Roxbury residents over age 50 in order to create a pilot health 
promotion program.  This study is spearheaded by the Center for Community Health Education 
Research and Service, Inc., which is nationally recognized as a model community-academic research 
partnership. 
B) Understanding and Addressing the Legal Needs of Refugees; Heather-Lyn Haley, PhD, Family 
Medicine and Community Health and Valerie Zolezzi-Wyndham, Esq., Community Legal Aid.  This 
study focuses on understanding the barriers refugees face when obtaining critical support services, 
benefits and housing.  The aim is to improve individual and systemic level advocacy and training 
strategies designed to reduce the barriers impeding access to public benefits and housing for 
Worcester’s growing and diverse refugee population. 
C) Simulation-based Community-engaged Research Intervention for Informed Consent Protocol 
Testing and Training (SCRIIPTT) Project; Jeroan Allison, MD, MS, Department of Quantitative 
Health Sciences and Marie Boone, MHS, VP of Mosaic Cultural Complex (Mosaic).  This project 
incorporates culturally and linguistically competent methods into the informed consent process using 
the expertise of community members.  Results of this work will be an increase engagement by 
communities of color in biomedical research.  This project is led by a team whose experiences include 
community health and community-engaged research, and builds upon the work of Mosaic, the UMass 
Center for Health Equity Intervention Research (CHEIR), the CCTS Bioethics, Core, and the UMMS 
Office of Educational Affairs’ Inter-professional Center for Experiential Learning and Simulation 
(iCELS). 
 
Format: 
Three, 20-minute presentations, with time after each presentation and at the end for questions, comments, and 
interaction. 
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6. DATA ACQUISITION, DATA MANAGEMENT, AND SUBJECT TRACKING IN CLINICAL AND 
TRANSLATIONAL RESEARCH: SEEKING SOLUTIONS TO PERSISTENT CHALLENGES 
 
Moderators: Mary Costanza, MD, Professor Emeritus, Department of Medicine, University of Massachusetts 
Medical School 
 
Bruce Barton, PhD, Research Professor, Department of Quantitative Health Sciences, 
University of Massachusetts Medical School 
 
Presenters: Roger Luckmann, MD, MPH, Associate Professor, Department of Family Medicine and 
Community Health, University of Massachusetts Medical School 
 
Dane Netherton, Database Administrator, Department of Quantitative Health Sciences, 
University of Massachusetts Medical School 
 
Rebecca Gore, PhD, Biostatistician/Programmer, University of Massachusetts Lowell  
 
Paul Ranauro, Research Software Engineer, UMMS Information Services, University of 
Massachusetts Medical School 
 
Background and Purpose: 
The implementation of clinical studies that involve recruiting and observing human subjects over time 
requires that data of many types be collected from subjects directly, and from electronic data sources (e.g. 
electronic health records, claims databases).  These data usually must be integrated into a single data system 
through the use of a variety of data collection interfaces (e.g. data entry and scanning applications, computer 
assisted telephone interviewing tools, data extraction programs, etc.) and then used to track subjects 
throughout the study period, to generate reports relevant to study management and ultimately to develop  
analytic datasets. 
As clinical studies become increasingly complex, the development of the supporting data systems 
presents many challenges including: 1) designing effective and complete field naming conventions, 2) handling 
potentially conflicting data from disparate sources, 3) designing routines for updating data fields in real time 
from external clinical data sources, 4) developing applications to support building customized data collection 
tools and report generators, and other challenges.  While some software applications (e.g., REDCap) are 
available that provide some of the functionality required to meet complex clinical research needs, much of the 
time custom software development  and database design are the only viable approaches to creating a system 
that meets all study needs.  These applications and interfaces are usually built by teams that may include 
researchers, software developers, database designers, data managers and/or data analysts who may have 
only limited experience in systematic approaches to confronting the complex challenges of data system design 
for clinical studies. 
We propose a symposium aimed at starting a dialogue among a diverse set of UMass faculty and staff 
who are involved in addressing the clinical data challenges described above.  The specific objectives of the 
symposium are: 1) to identify and characterize important and recurring challenges to data acquisition and 
management and subject tracking, 2) to identify local resources (e.g. consultants, specialized information 
system teams, software developers) that could facilitate clinical data system design and implementation for 
UMass research studies, and 3) to explore potential solutions to common data problems and additional 
resources needed to address identified challenges. 
 
Format: 
The symposium will open with a 10 minute case presentation by Dr. Luckmann focusing on common 
challenges arising from his clinical research experience in the development and implementation of complex 
data systems.  A summary of this case study presentation will be provided to other panel members one week 
before the symposium to allow them to prepare comments on the issues he raises. 
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Each subsequent presenter will have 10 minutes to address one or more of the issues arising from Dr. 
Luckmann’s presentation and to share challenges and solutions to design problems they have identified in their 
own work. 
 
This  format will allow for 40-45 minutes for the moderators to engage the panel and the audience in a 
discussion aimed at defining the most important issues to be addressed, the most promising approaches to 
address them  and the resources required to respond to the data system development needs identified. 
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7. DIVERGENT IMPACTS OF PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR ON GLUCOSE 
INTOLERANCE AND VASCULAR FUNCTION: FROM LABORATORY TO CLINIC 
 
Moderator: Barry Braun, PhD, Professor, Department of Kinesiology, University of Massachusetts Amherst 
 
Shaila V. Chauhan, MD, Assistant Professor of Obstetrics and Gynecology, University of 
Massachusetts Medical School 
 
Presenters: Sarah Witkowski, PhD, Assistant Professor, Department of Kinesiology, University of 
Massachusetts Amherst 
 
Barry Braun, PhD, Professor, Department of Kinesiology, University of Massachusetts Amherst 
 
Lisa Chasan-Taber, ScD, Professor, Epidemiology and Biostatistics, Department of Public 
Health, University of Massachusetts Amherst 
 
Background, Purpose and Scientific Issues to Be Addressed: 
Lack of sufficient physical activity is strongly associated with increased risk for Type-2 diabetes, gestational 
diabetes and cardiovascular disease.  The pathophysiology of all three disorders is characterized by insulin 
resistance, glucose intolerance and endothelial dysfunction.  Habitual exercise opposes all of those conditions 
and reduces risk for making the transition from insulin resistance compensated by hyperinsulinemia to overt 
clinical diagnosis.  Although the influence of increasing physical activity is reasonably well understood, the 
impact of increased sedentary behavior (e.g. time spent sitting) is less clearly understood.  The separate roles 
of physical activity and sedentary behavior in the underlying mechanisms and clinical manifestations of insulin 
resistance/glucose intolerance/vascular dysfunction are just now being elucidated.  Despite the lack of 
compelling data, the media have unleashed a blizzard of attention about the benefits of less time spent sitting, 
with headlines touting the use of treadmill desks, walking meetings, etc., to enhance health and lower health-
care costs, e.g., “Stand-up desks can add years to your life”, Miami Herald, 5/21/12.  “The health benefits of 
working on your feet”, Denver Post, 9/5/11.  “Companies take a stand against sitting”, San Francisco 
Chronicle, 8/8/12. 
 
Despite the media frenzy, there are almost no experimental data that compare the efficacy of reduced sitting 
with the better established efficacy of daily physical activity.  In this mini-symposium, the three speakers will 
show data on the role of increased physical AND sedentary behavior in mediating Type-2 diabetes, gestational 
diabetes and cardiovascular disease.  In addition, they make connection to the impact on clinical practice and 
discuss future directions. 
 
Format: 
Introduction: Shaila Chauhan (5 min) 
 
Three speakers: 20 minute presentations (60 min total) 
 
Discussion (25 min) 
Questions from audience (10 minutes) 
Discussion of how the results potentially affect/change clinical practice (15 min) 
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8. PHYSICAL ACTIVITY, SEDENTARY BEHAVIOR AND FUNCTION IN INDIVIDUALS WITH KNEE AND 
HIP OSTEOARTHRITIS: CLINICAL OBSERVATIONS AND OPPORTUNITIES FOR FUTURE 
RESEARCH 
 
Moderator: David Ayers, MD, Professor and Chair, Department of Orthopedics and Rehabilitation, 
University of Massachusetts Medical School 
 
Presenters: Patty Freedson, PhD, Professor and Chair, Department of Kinesiology, University of 
Massachusetts, Amherst 
 
Amanda Hickey, MS, Doctoral Candidate, Department of Kinesiology, University of 
Massachusetts, Amherst 
 
Patricia Franklin, MD, MPH, MBA, Professor, Department of Orthopedics and Rehabilitation, 
University of Massachusetts Medical School 
 
Background, Purpose and Scientific Issues to Be Addressed: 
Background - Osteoarthritis (OA) has negative effects on quality of life due to pain which impacts the ability to 
carry out activities of daily living.  Osteoarthritis affects 27 million people in the US1 and annual medical costs 
are estimated to be $89.1 billion2.  Thus, it is desirable to examine possible strategies and interventions that 
may be effective in improving quality of life and reducing costs in individuals with OA.  Physical activity has 
positive effects on functional capacity in knee and hip OA patients but evidence has also shown that as OA 
progresses, physical activity declines.  Most of the evidence examining OA and physical activity use self-report 
tools to quantify physical activity behavior.  These subjective assessment measures are prone to recall bias 
and differential errors in reporting.  Purpose - This symposium will highlight research results from a Life 
Science Moment Fund project that used wearable monitors to objectively quantify changes in physical activity 
and sedentary behavior in individuals with moderate to severe knee and/or hip OA.  These patients were 
undergoing conservative treatments (e.g. physical therapy, medications) and we monitored them with wearable 
sensors every 3 mos for 9 mos.  Scientific/Translational Issues - We will present the physical activity and 
sedentary behavior results and examine these measures in relation to commonly used self-report measures of 
pain and function.  Use of objective tools to quantify physical activity and sedentary behavior in large clinical 
trials examining OA, obesity, or various interventions to reduce pain and improve function will also be 
discussed. 
 
1Lawrence et al. Arthritis Rheum., 2008 
2Leigh et al., Rheumatol., 2001 
 
Format: 
1) Introduction:  David Ayers (5 min) 
2) Three speakers:  20 minute presentations (60 min total) 
3) Discussion (25 min) 
a. Answer questions from audience (10 minutes) 
b. Pose issues for discussion to audience for feedback (e.g. how can this work be expanded to 
integrate basic science research?)  (15 min) 
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9. MANIPULATING THE GUT MICROBIOME FOR HUMAN HEALTH 
 
Moderators: Beth A. McCormick, PhD, Professor, Department of Microbiology & Physiological Systems, 
University of Massachusetts Medical School 
 
Jeffrey Blanchard, PhD, Associate Professor, Department of Biology, University of 
Massachusetts Amherst 
 
Presenters: Randall Pellish, MD, Assistant Professor, Division of Gastroenterology, Department of 
Medicine, University of Massachusetts Medical School 
 
Vanni Bucci, PhD, Assistant Professor, Department of Biology, University of Massachusetts 
Dartmouth 
 
Barbara Olendzki, MPH, RD, LDN, Assistant Professor, Center of Applied Nutrition, University 
of Massachusetts Medical School 
 
David Sela, PhD, Assistant Professor, Department of Food Science, University of 
Massachusetts Amherst 
 
Background and Purpose: 
Mounting evidence suggests that particular aspects of human health and disease may be attributable to the 
trillions of microbes that inhabit our gastrointestinal tract, collectively referred to as the gut microbiota.  The gut 
microbial communities contribute to human health and survival in a variety of critical ways, including facilitating 
nutrient acquisition and immune development and providing protection against introduced pathogens.  The 
recent realization of the power of the gut microbiome in regulating human health and disease is a major 
advancement and provides a new potential target for the maintenance of health and prevention and therapy for 
some human diseases.  Evidence suggests that pathologic changes to the microbiota (termed “dysbiosis”) are 
associated with a wide variety of medical outcomes, and therefore therapeutic manipulation of the microbiota is 
a major area of research interest.  However, the complex and interconnected nature of this population poses a 
major challenge for the development of interventions.  We propose a mini symposium with the goal of fostering 
an interdisciplinary discussion among practitioners, dieticians, nutritionists, as well as basic/clinical scientists 
interested in the gut microbiome and its role in health and disease.  We will facilitate this goal by focusing on 
two important clinical diseases known to be associated with dysbiosis, Inflammatory Bowel Disease and 
Clostridium difficile colitis, and inviting clinical and basic researchers to present their diverse perspectives on 
potential therapeutic interventions.  Approaches for manipulating the gut microbiome through diet, targeted 
antibiotic therapy, provision of specific cocktails of select bacteria, and fecal microbiota transplantation for 
health and disease are under investigation or use.  Keeping abreast of this rapidly moving field and realizing 
how these findings could possibly be extrapolated to the clinical setting is difficult, yet an understanding of the 
mechanisms and potential clinical applications is imperative.  The gut microbiome offers myriad possibilities to 
basic and translational researchers, clinicians and patients.  Thus, UMass thought leaders in the field of 
microbiome research will present session lectures and participate in a follow-up interactive, discussion-based 
workshop on topics related to attempts to manipulate the gut microbiota to improve health.  
 
Format: 
Introduction by Moderators: 
Drs. McCormick and Blanchard (10 min) 
C. dificile infection: 
Clinical gut manipulation: Dr. Randy Pellish - Fecal Transplantation (15 min) 
Basic research approach: Dr. Vanni Bucci - Antibiotic Treatment (15 min) 
Intestinal Disease: 
Clinical gut manipulation: Barbara Olendzki - Dietary Interventions (15 min) 
Basic research approach: David Sela - Probiotic Delivery (15 min) 
Interactive Discussion/Workshop on Relevant Topics: (20 min) 
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10. SYSTEMS SCIENCE AND HEALTH: USING ANALYTICAL APPROACHES TO EVALUATE 
HEALTHCARE POLICY DECISIONS 
 
Moderators: Isa Bar-On, PhD, Department of Mechanical Engineering, Worcester Polytechnic Institute 
 
Allison Rosen, MD, MPH, ScD, Quantitative Health Sciences, University of Massachusetts 
Medical School 
 
Presenters: Tze Chao Chiam, PhD, Quantitative Health Sciences, University of Massachusetts Medical 
School 
 
Renata Konrad, PhD, School of Business, Worcester Polytechnic Institute 
 
Oleg Pavlov, PhD, Social Science & Policy Studies, Worcester Polytechnic Institute 
 
Khalid Saeed, PhD, Social Science & Policy Studies, Worcester Polytechnic Institute 
 
Shamsnaz Virani, PhD, Systems Engineering and Leadership Institute, Worcester Polytechnic 
Institute 
 
Background and Purpose: 
The focus of this symposium is on systems science applications to health research.  Systems science is a 
collection of analytical computer simulation techniques which are used to evaluate optimize and improve 
healthcare delivery processes.  These techniques account for the complexity of the healthcare system and 
healthcare processes by modeling nonlinear relationships between variables, the feedback effects, delays and 
soft variables.  The analysis stresses heterogeneity of agents, resistance to change, potential unintended 
consequences, and behavioral emergence in complex systems.  Such models use historical data to simulate 
the operations of healthcare systems providing an approximation of future outcomes.  The presenters will 
discuss several different types of simulations methods, highlight recent advances, and describe funding 
opportunities from the National Institutes of Health.  Examples from chronic disease patient chains, physician 
incentive redesign, clinic staffing and Emergency Department redesign will be discussed. 
 
Emergency Department:  Consider an Emergency Department that is contemplating a decision to add beds in 
an effort to reduce wait times.  It is not certain the degree to which additional beds would reduce congestion or 
the financial viability of such an option.  It is not, however, practical to add beds and later have to remove them 
if the anticipated results are not obtained.  Simulation is used when the proposed change cannot be 
implemented without a significant change in practice that may be too disruptive or too expensive.  A computer 
simulation provides the ability to assess trade-offs among resource utilization, service quality and costs. 
 
A Chronic Disease Patient Chain:  Chronic diseases are not like infectious diseases.  Chronic diseases often 
progress slowly and are not communicated to others by patients.  At some point, a radical surgical procedure 
such as an organ transplant might be required when expected benefits of the surgery outweigh its risks.  We 
will discuss a computer model that simulates the diagnosis and treatment of patients with acute kidney failure.  
The core of the model is a patient chain, in which new cases flow into a stock of diagnosed cases of acute 
renal failure.  Every time period, a fraction of these patients are referred to become candidates for kidney 
transplants, yet a fraction of them die before they are scheduled for a surgery.  These candidates for transplant 
then undergo the transplant procedure, die while on the waitlist, or are removed from the waitlist if their 
condition deteriorates and it becomes unsuitable for surgery. 
 
Format: 
The format will be a mix of presentations and demonstrations with an interactive discussion.  
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11. ADVANCED COMPUTATIONAL AND TECHNOLOGICAL APPROACHES TO MITIGATING MOBILITY 
DYSFUNCTION IN PEOPLE WITH MULTIPLE SCLEROSIS 
 
Moderator: Richard van Emmerik, PhD, Professor and Director, Sensory-Motor Control Laboratory, 
Department of Kinesiology, UMass Amherst 
 
Presenters: 
 
Carolina Ionete, MD, PhD, Associate Professor of Clinical Neurology, Associate Director, Multiple Sclerosis 
Center, UMass Memorial Health Care 
 
Introduction to Clinical Issues and Mobility in MS - Along with Dr. Peter Riskind, Director of the UMass 
Memorial Health Care MS Center, and Profs. Richard van Emmerik and Jane Kent-Braun from UMass 
Amherst, Dr. Ionete has been part of the inter-campus UMass MS collaborative research effort since its 
inception.  Dr. Ionete will present an introduction to the topic, focusing on the key clinical issues related to 
mobility challenges in people with MS. 
 
Stephanie Jones, PhD, Research Assistant Professor, Sensory-Motor Control Laboratory, Department of 
Kinesiology, UMass Amherst 
 
Somatosensory Impairment and Balance Dysfunction in MS – Impaired balance and gait function are 
highly prevalent and associated with reduced quality of life in those with MS.  Recent evidence implicates the 
somatosensory system as a major contributor to balance dysfunction in this population.  This presentation will 
discuss evidence supporting the role of reduced somatosensation in balance for those with MS and introduce a 
new paradigm to assess sensation during functional postures in the clinical and laboratory settings. 
 
Richard van Emmerik, PhD, Professor and Director, Sensory-Motor Control Laboratory, Department of 
Kinesiology, UMass Amherst 
 
Improving Balance and Mobility in People with Multiple Sclerosis - This presentation will review current 
intervention and rehabilitation methods aimed at improving balance and mobility in people with MS.  Particular 
focus will be on the effects of Tai Chi training, which integrates coordination, strength and flexibility in 
enhancing adaptive postural control and physical function. 
 
Frank Sup, PhD, Assistant Professor and Director of the Mechatronics and Robotics Research Laboratory, 
Department of Mechanical and Industrial Engineering, UMass Amherst 
 
Using Robotics to Enhance a Person's Mobility and Balance - Wearable robotic exoskeletons are 
becoming a reality for restoring mobility for individuals with spinal cord injury.  However, these devices are not 
designed to be used by individuals with MS or other conditions that result in functional, yet diminished, motor 
control.  This talk will cover the development of ambulatory aids and exoskeletons for individuals with mobility 
impairments, with special application to the MS population. 
 
Background and Purpose: 
Background:  Multiple sclerosis (MS) is the most common neurological disorder striking adults aged 20-50 
years.  Its heterogeneous presentation and clinical course, along with as-yet-unclear etiology, make it 
particularly difficult to treat and manage.  Fatigue and poor mobility function are two of the most common 
symptoms in this population, and these problems have significant negative impacts on both quality of life and 
risk for the development of other chronic health issues related to inactivity.  In this mini-symposium, we will 
provide an overview of mobility dysfunction in MS, and present our recent, current and future research related 
to mobility.  An emphasis will be placed on how we might use emerging opportunities and approaches to 
reverse key limitations to mobility currently experienced by this population.  
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Purpose:  To introduce the audience to the clinical and mechanistic underpinnings of mobility impairments 
common in people with multiple sclerosis, and provide insight as to emerging, interdisciplinary approaches to 
solving this problem. 
 
Format: 
Four, 15-minute talks, each followed by a 3-minute Q&A period. 
 
Panel Discussion (18 min) 
Open discussion with the audience and speakers, with a focus on making connections with other 
researchers, and identifying other approaches and opportunities to investigate as part of the UMass MS 
research program. 
